ES
41
-9
APA
46
-2
AEE
45
-13
PM
56
-4
KMX
40
-2
OMC
37
-3
XRX
37
-2
SLG
49
-3
IFF
26
-15
AVGO
30
5
GS
33
-6
EMR
64
2
VLO
45
-3
NRG
35
-2
CMS
55
-3
PLD
23
-2
AA
16
-10
PPG
41
2
PG
45
-3
FOX
31
-8
ES
41
-9
APA
46
-2
AEE
45
-13
PM
56
-4
KMX
40
-2
OMC
37
-3
XRX
37
-2
SLG
49
-3
IFF
26
-15
AVGO
30
5
GS
33
-6
EMR
64
2
VLO
45
-3
NRG
35
-2
CMS
55
-3
PLD
23
-2
AA
16
-10
PPG
41
2
PG
45
-3
FOX
31
-8
Financhill
Back

Actinium Pharmaceuticals 10K Form

Sell
48

ATNM
Actinium Pharmaceuticals

Last Price:
6.23
Seasonality Move:
-2.18%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ATNM News And Ratings

See the #1 stock for the next 7 days that we like better than ATNM

ATNM Financial Statistics

Sales & Book Value

Annual Sales: $1.03M
Cash Flow: $-13.69M
Price / Cash Flow: 0
Annual Sales: $1.97
Price / Book: 3.2

Profitability

EPS (TTM): -1.82000
Net Income (TTM): $-46.34M
Gross Margin: $0
Return on Equity: 0%
Return on Assets: 0%

Actinium Pharmaceuticals Earnings Forecast

Key Actinium Pharmaceuticals Financial Ratios

  • The Selling, General & Administrative Expenses for ATNM have been equal to 1,165.05% of Gross Profit Margin.
  • The Research & Development expenses have been 2,246.60% of Revenue.
  • The Interest Expense is -0.04% of Operating Income.
  • Per Share Earnings over the last 17 years have been positive in 9 years.

Actinium Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYAM
Industry: Biotechnology
Sector: Healthcare
Current Symbol: ATNM
CUSIP: 00507W
Website: actiniumpharma.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ATNM Technical Analysis vs Fundamental Analysis

Sell
48
Actinium Pharmaceuticals (ATNM) is a Sell

Is Actinium Pharmaceuticals a Buy or a Sell?